Maker of popular diabetes and weight loss drugs grilled about high cost in the U.S.
Sort by
549 items
-
NBC News - Top stories
Maker of popular diabetes and weight-loss drugs grilled about high cost in the U.S.
The CEO of Novo Nordisk was questioned about the high cost in the U.S. of Wegovy and Ozempic, the wildly popular diabetes and weight-loss drugs. Lars Jorgensen said pharmacy benefit managers are ...6 hours ago -
CNBC - Business
'Stop ripping us off': Senate grills Novo Nordisk CEO on weight loss drug pricing
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.7 hours ago -
NBC News - Top stories
Ozempic CEO agrees to discuss lower prices for blockbuster weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO testified on Capitol Hill Tuesday.8 hours ago -
CBS News - Top stories
Ozempic, Wegovy maker grilled by Bernie Sanders-led committee over high prices
The Senate Health, Education, Labor and Pension committee, led by Vermont Sen. Bernie Sanders, is hearing testimony from Novo Nordisk CEO Lars Fruergaard Jørgensen on the exhortative prices for ...10 hours ago -
ABC News - World
Two powerful unions join protests in Martinique over the high cost of living
Two powerful unions on the French Caribbean island of Martinique have joined protests against high living costs that recently have prompted France to send anti-riot police10 hours ago -
CNBC - Business
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an antitrust suit against Epic Systems.11 hours ago -
ABC News - Tech
Vista, Blackstone buying software maker Smartsheet for about $8.4 billion
Private equity firms Vista Equity Partners and Blackstone are buying software maker Smartsheet for approximately $8.4 billion in cash13 hours ago -
MarketWatch - Business
Consumer confidence plunges on weaker job market and high cost of living. Americans are anxious ahead of election.
Consumer confidence fell in September to a three-month low ahead of a pivotal U.S. election whose outcome could hinge on which presidential candidate voters think will do a better job on the economy.14 hours ago -
MarketWatch - Business
4 things you need to know about Medicare drug costs and coverage in 2025
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy counter next year need to stay vigilant in the coming months.15 hours ago -
The Hill - Politics
Watch live: Senate HELP committee grills Novo Nordisk on weight loss drug pricing
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo Nordisk CEO Lars Jorgenson Tuesday morning over prices on the ...15 hours ago -
CBS News - Top stories
CEO of company of popular weight loss drugs to face Senate questions over high costs in U.S.
Senior investigative consumer correspondent Anna Werner looked into the high prices of weight loss drugs in the U.S. as research shows Americans pay far more for some of the popular drugs compared ...15 hours ago -
CBS News - Top stories
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.15 hours ago -
Financial Times - Business
Akzo Nobel to cut 2,000 jobs as high costs bite
Owner of Dulux paint seeks to ‘become more agile’ after shrinking workforce by roughly 5%20 hours ago -
CBS News - Top stories
Fentanyl fuels worst drug crisis in U.S. history
60 Minutes correspondent Bill Whitaker breaks down how fentanyl has been spreading through the U.S., quickly becoming America's worst drug crisis. Whitaker visited the border with Mexico to see how ...Yesterday -
MarketWatch - Business
U.S. business activity suffers small loss of momentum in September, PMI shows
Optimism about the outlook in the year ahead deteriorated sharply to the lowest level since October 2022, in part due to uncertainty regarding the presidential election.Yesterday -
ABC News - World
The cost of Germany's popular transport ticket will rise significantly
The cost of a popular ticket that allows people to use all local and regional trains, buses and subway systems across Germany is set to increase by about 18% next yearYesterday -
-
Financial Times - World
Novo Nordisk faces US Senate grilling over price of weight loss drugs
Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ Americans2 days ago -
CBS News - Top stories
U.S. "losing a generation" to deadly fentanyl, DEA head says
Fentanyl, which is often hidden in counterfeit pills, is fueling the worst drug crisis in U.S. history. Last year the synthetic opioid killed more than 70,000 Americans.2 days ago -
The Guardian - World
No promotions, no buzz. Home workers pay high price while bosses save on costs | Martha Gill
Labour’s legislation confronting a ‘culture of presenteeism’ may inadvertently favour employers and cause the badly paid to lose out. At the age of 25, casting around for what to do next, I was ...2 days ago -
CBS News - Top stories
As weight loss drugs explode in popularity, are online marketplaces safe?
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other ...3 days ago -
CBS News - Top stories
Inside the thriving market for alternatives to brand-name weight loss drugs
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.3 days ago -
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.4 days ago -
Financial Times - Business
Deadly flood losses mount as insurers and governments tally costs
Brussels’ pledge of up to €10bn following European floods comes as insurers face estimated €3bn in claims4 days ago -
Inc. - Business
U.S. to Distribute $3 Billion in Grants to 25 Battery Makers
support 12,000 production and construction jobs4 days ago -
CNBC - Business
64% of U.S. retirement savers make this 'dangerous' assumption—'avoid it at all costs,' says CFP
The majority of Americans aren't planning for more than 20 years of retirement. Things could get ugly if they live longer or leave work sooner than expected.4 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago